McGregor IS et al. |
A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. |
1998 |
Brain Res. |
pmid:9748483
|
Schneider U et al. |
Cannabinoid/anandamide system and schizophrenia: is there evidence for association? |
1998 |
Pharmacopsychiatry |
pmid:9754842
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Pestonjamasp VK and Burstein SH |
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. |
1998 |
Biochim. Biophys. Acta |
pmid:9795237
|
White R and Hiley CR |
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. |
1998 |
Br. J. Pharmacol. |
pmid:9806337
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Aceto MD et al. |
Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808686
|
Murillo-RodrÃguez E et al. |
Anandamide modulates sleep and memory in rats. |
1998 |
Brain Res. |
pmid:9813364
|
Jaggar SI et al. |
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. |
1998 |
Neurosci. Lett. |
pmid:9774165
|
Fields HL and Meng ID |
Watching the pot boil. |
1998 |
Nat. Med. |
pmid:9734389
|
Pate DW et al. |
Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. |
1998 |
Life Sci. |
pmid:9851310
|
Molina-Holgado F et al. |
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. |
1998 |
FEBS Lett. |
pmid:9738948
|
Patel NA et al. |
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. |
1998 |
Brain Res. |
pmid:9666136
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Stefano GB et al. |
Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. |
1998 |
Int. J. Cardiol. |
pmid:9687087
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Prevot V et al. |
Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. |
1998 |
Brain Res. |
pmid:9593913
|
Di Marzo V |
'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. |
1998 |
Biochim. Biophys. Acta |
pmid:9630590
|
Schmid PC et al. |
Alternative pathways of anandamide biosynthesis in rat testes. |
1998 |
Chem. Phys. Lipids |
pmid:9631536
|
Varga K et al. |
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. |
1998 |
FASEB J. |
pmid:9707176
|
Mallet PE and Beninger RJ |
Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. |
1998 |
Life Sci. |
pmid:9651110
|
De Petrocellis L et al. |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9653194
|
Berdyshev E et al. |
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. |
1998 |
Life Sci. |
pmid:9718090
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Bisogno T et al. |
Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703957
|
Kondo S et al. |
Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. |
1998 |
Arch. Biochem. Biophys. |
pmid:9637740
|
Stefano GB et al. |
Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641464
|
Stefano GB et al. |
Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. |
1998 |
J. Cardiovasc. Pharmacol. |
pmid:9641470
|
Mallet PE and Beninger RJ |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. |
1998 |
Psychopharmacology (Berl.) |
pmid:9862397
|
Stahl SM |
Getting stoned without inhaling: anandamide is the brain's natural marijuana. |
1998 |
J Clin Psychiatry |
pmid:9862600
|
Bonhaus DW et al. |
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9864268
|
Ueda N et al. |
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors. |
1998 |
J. Med. Invest. |
pmid:9864962
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Navarro M and RodrÃguez de Fonseca F |
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. |
1998 |
Neurobiol. Dis. |
pmid:9974172
|
Di Marzo V and Deutsch DG |
Biochemistry of the endogenous ligands of cannabinoid receptors. |
1998 |
Neurobiol. Dis. |
pmid:9974173
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|
Maccarrone M et al. |
Anandamide hydrolysis by human cells in culture and brain. |
1998 |
J. Biol. Chem. |
pmid:9822713
|
Derocq JM et al. |
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. |
1998 |
FEBS Lett. |
pmid:9563506
|
Chakrabarti A et al. |
Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. |
1998 |
Brain Res. Bull. |
pmid:9434204
|
Lin S et al. |
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. |
1998 |
J. Med. Chem. |
pmid:9876105
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Axelrod J and Felder CC |
Cannabinoid receptors and their endogenous agonist, anandamide. |
1998 |
Neurochem. Res. |
pmid:9566594
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Di Marzo V et al. |
Interactions between synthetic vanilloids and the endogenous cannabinoid system. |
1998 |
FEBS Lett. |
pmid:9801167
|
Van der Kloot W et al. |
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions. |
1998 |
J. Physiol. (Lond.) |
pmid:9508830
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Giuffrida A and Piomelli D |
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
1998 |
FEBS Lett. |
pmid:9498819
|
Tong W et al. |
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. |
1998 |
J. Med. Chem. |
pmid:9784095
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Hampson AJ et al. |
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. |
1998 |
J. Neurochem. |
pmid:9453561
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|
Pratt PF et al. |
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. |
1998 |
Am. J. Physiol. |
pmid:9458889
|
Paria BC et al. |
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. |
1998 |
Biol. Reprod. |
pmid:9623610
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|
Brăiloiu C et al. |
[Endothelium-derived hyperpolarizing factor]. |
1998 Jul-Dec |
Rev Med Chir Soc Med Nat Iasi |
pmid:10756843
|
Childers SR and Breivogel CS |
Cannabis and endogenous cannabinoid systems. |
1998 Jun-Jul |
Drug Alcohol Depend |
pmid:9716939
|
Chaytor AT et al. |
The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. |
1999 |
J. Physiol. (Lond.) |
pmid:10523421
|
Piomelli D et al. |
Structural determinants for recognition and translocation by the anandamide transporter. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10318965
|
Mombouli JV et al. |
Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells. |
1999 |
Br. J. Pharmacol. |
pmid:10323591
|
Watanabe K et al. |
Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride. |
1999 |
Biol. Pharm. Bull. |
pmid:10328555
|
Mechoulam R and Ben-Shabat S |
From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. |
1999 |
Nat Prod Rep |
pmid:10331283
|
Burstein SH |
The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. |
1999 |
Pharmacol. Ther. |
pmid:10341359
|
Di Marzo V et al. |
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. |
1999 |
Lipids |
pmid:10419192
|
Hansen HS et al. |
Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. |
1999 |
Lipids |
pmid:10419193
|
Kiss Z |
Anandamide stimulates phospholipase D activity in PC12 cells but not in NIH 3T3 fibroblasts. |
1999 |
FEBS Lett. |
pmid:10214947
|
Maccarrone M et al. |
Anandamide activates human platelets through a pathway independent of the arachidonate cascade. |
1999 |
FEBS Lett. |
pmid:10214961
|
Yang HY et al. |
GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. |
1999 |
J. Neurochem. |
pmid:10217273
|
Raffa RB et al. |
Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice. |
1999 |
Neurosci. Lett. |
pmid:10218903
|
De Petrocellis L et al. |
Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. |
1999 |
Neuroscience |
pmid:10392859
|
Williams CM and Kirkham TC |
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. |
1999 |
Psychopharmacology (Berl.) |
pmid:10353436
|
Fimiani C et al. |
Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. |
1999 |
Cell. Signal. |
pmid:10353693
|
Ng EW et al. |
Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. |
1999 |
J. Med. Chem. |
pmid:10354405
|
Járai Z et al. |
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10570211
|
Sagan S et al. |
Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. |
1999 |
Eur. J. Neurosci. |
pmid:10051770
|
Kobayashi H et al. |
Recent progress in the neurotoxicology of natural drugs associated with dependence or addiction, their endogenous agonists and receptors. |
1999 |
J Toxicol Sci |
pmid:10073332
|
Bisogno T et al. |
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10079192
|
Fleming I et al. |
Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. |
1999 |
Br. J. Pharmacol. |
pmid:10193775
|
Hohmann AG et al. |
Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. |
1999 |
Brain Res. |
pmid:10082879
|
Wang J et al. |
Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. |
1999 |
Biol. Reprod. |
pmid:10084956
|
Ishioka N and Bukoski RD |
A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10087011
|
Wiley JL |
Cannabis: discrimination of "internal bliss"? |
1999 |
Pharmacol. Biochem. Behav. |
pmid:10515300
|
Howlett AC et al. |
Signal transduction of eicosanoid CB1 receptor ligands. |
1999 |
Life Sci. |
pmid:10462062
|
Di Marzo V |
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. |
1999 |
Life Sci. |
pmid:10462065
|
Ueda N et al. |
An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. |
1999 |
FEBS Lett. |
pmid:10431820
|
Fowler CJ et al. |
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. |
1999 |
Arch. Biochem. Biophys. |
pmid:9989926
|
Basavarajappa BS and Hungund BL |
Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells. |
1999 |
J. Neurochem. |
pmid:9930723
|
Wagner JA et al. |
Mesenteric vasodilation mediated by endothelial anandamide receptors. |
1999 |
Hypertension |
pmid:9931142
|
Goparaju SK et al. |
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. |
1999 |
Biochem. Pharmacol. |
pmid:9933030
|
Lu R et al. |
Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. |
1999 |
Am. J. Physiol. |
pmid:9950961
|
Gifford AN et al. |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). |
1999 |
Eur. J. Pharmacol. |
pmid:10556675
|
Melck D et al. |
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. |
1999 |
FEBS Lett. |
pmid:10606728
|
Gebremedhin D et al. |
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. |
1999 |
Am. J. Physiol. |
pmid:10362691
|